HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Doctors with students.

Streamlining Multisite Clinical Trials

NCATS SMART IRB Reliance Platform to serve as roadmap for new NIH policy.

Work with Us

NCATS aims to address common barriers in clinical and translational research that scientists nationwide face every day, with the goal of delivering more treatments to more patients more quickly.

Contact the Division of Clinical Innovation

Clinical Innovation

NCATS supports innovation in new technologies and other clinical and translational approaches that may greatly accelerate the process of transforming laboratory discoveries into new treatments for patients.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

Clinical & Translational Science Awards (CTSA) Program

The CTSA Program is designed to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care.

    Rare Diseases Clinical Research Network (RDCRN)

    The RDCRN is designed to advance medical research on rare diseases by facilitating collaboration, study enrollment and data sharing.

    Patient Registries

    Patient and contact registries are key tools that help researchers identify potential clinical study participants, including health volunteers.

      Clinical Research Toolbox

      NCATS is positioned to help transform the clinical steps of translation and is dedicated to supporting the networks, tools and resources that will improve patient-centered research. 

        Addressing Clinical Research Challenges

        Researchers nationwide face common barriers in clinical and translational research that can delay the development of new interventions for patients in need. These challenges include:

        • Difficulties in recruiting, mentoring and retaining a critical mass of qualified clinical and translational investigators
        • Increased research costs and complexity
        • Low patient recruitment and retention in clinical research studies
        • Inflexible study designs
        • Increased regulatory burdens

        NCATS supports innovative programs, such as the Clinical and Translational Science Awards (CTSA) Program and Rare Diseases Clinical Research Network (RDCRN), to help address these challenges.